John Klein serves as the chairman of Cambridge Therapeutics, which he founded. He oversees the company’s activity in combination drug therapies, drug delivery systems, and physician prescription dispensation development.


  • Chairman

    at Cambridge Therapeutic Technologies

    January 2011 - at Present

    New Jersey

    John Klein has served in executive capacities for several pharmaceutical and physician service-related companies, beginning in 1988 when he became the president and CEO of Zenith Laboratories. Successful in growing revenue to $250 million and securing a purchase price of $600 million, John Klein received Business Week’s Turnaround of the Year Award for his success.

  • Chairman & CEO

    at Dava Pharmaceutical Company

    January 2005 - at Present

    New Jersey


  • English Native